Oestrogen receptor-positive (ER+), human epidermal growth factor receptor 2 negative (HER2−) breast cancers comprise the majority of breast cancer diagnoses and, as a proportion of all breast cancers, are increasing in incidence [1]. Here, ERBB2 is linked to breast cancer.